Article
Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation.
Therapeutic drug monitoring - 1 Oct 2018
Phupradit Annop, Vadcharavivad Somratai, Ingsathit Atiporn, Kantachuvesiri Surasak, Areepium Nutthada, Sra-Ium Supasil, Auamnoy Titinun, Sukasem Chonlaphat, Sumethkul Vasant, Kitiyakara Chagriya
Abstract excerpt
BACKGROUND: Tacrolimus, a critical dose drug, is widely used in transplantation. Knowing the contribution of genetic factors, which significantly influence tacrolimus variability, is beneficial in the personalization of its starting dose. The significant impact of CYP3A5*3 polymorphisms on tacrolimus exposure has been reported. Conflicting results of the additional influence of POR*28 polymorphisms on tacrolimus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
